Results 21 to 30 of about 105,845 (307)

Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. [PDF]

, 2012
The disease burden due to hepatitis B virus (HBV) infection remains significant; 350 million people are infected world-wide, and around half a million deaths each year are due to HBV-related liver disease and hepatocellular carcinoma (HCC).
Hall, Andrew J, Andrew J. Hall, Branwen J. Hennig, Hennig, Branwen J   +3 more
core   +1 more source

Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine

Human Vaccines & Immunotherapeutics, 2017
In China, both inactivated hepatitis A (HA) vaccine and live attenuated HA vaccine are available. We conducted a trial to evaluate 5-year immune persistence induced by one dose of inactivated or live attenuated HA vaccines in children.
Zhilun Zhang, Xiangjun Zhu, Yuansheng Hu, Miao Liang, Jin Sun, Yufei Song, Qi Yang, Haiquan Ji, Gang Zeng, Lifei Song, Jiangting Chen   +10 more
doaj   +1 more source

Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017

Human Vaccines & Immunotherapeutics, 2019
Backgroud: Beijing was hyper-endemic for hepatitis A until the 1990s and has been vaccinating against hepatitis A since 1994. The objective is to study the epidemiology and changes of antibody level of hepatitis A from 1990 to 2017. Methods: A multistage
Huai Wang, Pei Gao, Weixin Chen, Shuang Bai, Min Lv, Wenyan Ji, Xinghuo Pang, Jiang Wu   +7 more
doaj   +1 more source

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen

Nature Communications, 2022
The hepatitis B vaccine is recognised as the most effective approach in reducing hepatitis-B-related morbidity; vaccine-escape mutations are however capable of infecting vaccinated individuals. In this work, authors aim to establish a hepatitis B vaccine
Ayaka Washizaki, Asako Murayama, Megumi Murata, Tomoko Kiyohara, Keigo Yato, Norie Yamada, Hussein Hassan Aly, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Yasumasa Goh, Ken J. Ishii, Hiroshi Yotsuyanagi, Masamichi Muramatsu, Koji Ishii, Yoshimasa Takahashi, Ryosuke Suzuki, Hirofumi Akari, Takanobu Kato   +19 more
doaj   +1 more source

Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs [PDF]

, 2012
Hepatitis E virus (HEV), the causative agent of hepatitis E, is primarily transmitted via the fecal-oral route through contaminated water supplies, although many sporadic cases of hepatitis E are transmitted zoonotically via direct contact with infected ...
Meng, Xiang-Jin, Sanford, Brenton J, Kenney, Scott P, Dryman, Barbara A, Córdoba, Laura, Opriessnig, Tanja   +5 more
core   +1 more source

The Current Approach of Hepatitis A Infections

Viral Hepatitis Journal, 2012
Hepatitis A is the most common form of acute viral hepatitis in the world. Major geographical differences in endemicity of hepatitis A are closely related tohygienic and sanitary conditions and other indicators of the level of socioeconomic development ...
Özlem YOLDAŞ, Aslı BULUT, Mustafa ALTINDİŞ   +2 more
doaj   +1 more source

The Impact of an Inactivated Hepatitis A Vaccine with One Dose in Brazil: A Retrospective Time-Series

Vaccines, 2021
Background: In 2014, a recommended one-dose of inactivated hepatitis A vaccine was included in the Brazilian National Immunization Program targeting children 12–24 months.
Ana Luiza Bierrenbach, Yoonyoung Choi, Paula de Mendonça Batista, Fernando Brandão Serra, Cintia Irene Parellada, Guilherme Silva Julian, Karina Nakajima, Thais das Neves Fraga Moreira   +7 more
doaj   +1 more source

Identification of hepatitis a virus mimotopes by phage display, antigenicity and immunogenicity [PDF]

, 2007
A phage-displayed peptide approach was used to identify ligands mimicking antigenic determinants of hepatitis A virus (HAV) for the first time. Bacteriophages displaying HAV mimotopes were isolated from a phage-display peptide library by affinity ...
Camacho, F., Perez, E.M., Amin, N., Aguilar, A., David I. Stott, Talavera, A., Arturo Talavera, Raiza Martinez, Frank Camacho, Nevis Amin, Ela M. Perez, Larralde, O.G., Alicia Aguilar, Martinez, R., Osmany G. Larralde, Stott, D.I.   +15 more
core   +1 more source

Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s [PDF]

Uisahak, 2020
This paper analyzes the research process of Kim Chung Yong (henceforth referred to as KIM), who presented the hepatitis B vaccine in South Korea. In South Korea, which had been called the Hepatitis Kingdom, KIM developed a vaccine material for hepatitis ...
Miyoung SHIN
doaj   +1 more source

Modelling the hepatitis B vaccination programme in prisons [PDF]

, 2005
A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introduced into selected prisons in England and Wales. Over the coming years it is anticipated this vaccination programme will be extended.
Edmunds, W. John, Gilbert, R. L., V. D. Hope, O. N. Gill, Andrews, Nicholas J., M. Piper, Gill, O. N., N. J. Andrews, Hope, V. D., Piper, M., R. L. Gilbert, N. J. Gay, Gay, N. J., Sutton, A. J., A. J. Sutton, W. J. Edmunds   +15 more
core   +1 more source